These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6389225)

  • 1. In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Diabetes; 1984 Nov; 33(11):1062-7. PubMed ID: 6389225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of biosynthetic human proinsulin action in isolated rat adipocytes.
    Ciaraldi TP; Brady D; Olefsky JM
    Diabetes; 1986 Mar; 35(3):318-23. PubMed ID: 3512342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of biosynthetic human proinsulin.
    Podlecki DA; Frank BH; Olefsky JM
    Diabetes; 1984 Feb; 33(2):111-8. PubMed ID: 6363165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of insulin binding to isolated swine adipocytes.
    Etherton TD; Walker OA
    Endocrinology; 1982 May; 110(5):1720-4. PubMed ID: 7042314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of biosynthetic human diarginylinsulin.
    Zeuzem S; Stahl E; Jungmann E; Zoltobrocki M; Schöffling K; Caspary WF
    Diabetologia; 1990 Feb; 33(2):65-71. PubMed ID: 2184062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M; Sasaoka T; Sugibayashi M; Iwanishi M; Shigeta Y
    Diabetes Res Clin Pract; 1989 Jun; 7(1):25-8. PubMed ID: 2666066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.
    Peavy DE; Brunner MR; Duckworth WC; Hooker CS; Frank BH
    J Biol Chem; 1985 Nov; 260(26):13989-94. PubMed ID: 4055768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of insulin and biosynthetic human proinsulin actions in cultured hepatocytes. Kinetics and biologic potencies.
    Ciaraldi TP; Brady D
    Horm Metab Res; 1990 May; 22(5):283-8. PubMed ID: 2112110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biologic potency and binding affinity of biosynthetic human insulin in isolated rat adipocytes.
    Sonne O; Foley JE; Gliemann J
    Diabetes Care; 1981; 4(2):250-1. PubMed ID: 7011738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of insulin and proinsulin in vitro on pathways of glucose utilization and lipid synthesis in the lactating rat mammary gland.
    Ahmed S; Sochor M; Tabidi I; McLean P
    Biochem Biophys Res Commun; 1988 Jul; 154(1):443-9. PubMed ID: 3293567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity binding sites for proinsulin in human IM-9 lymphoblasts.
    Jehle PM; Lutz MP; Fussgaenger RD
    Diabetologia; 1996 Apr; 39(4):421-32. PubMed ID: 8777991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation, receptor binding affinity, and potency of insulin from the Atlantic hagfish (Myxine glutinosa) determined in isolated rat fat cells.
    Gammeltoft S; Gliemann J
    J Biol Chem; 1977 Jan; 252(2):602-8. PubMed ID: 556725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytotic uptake, processing, and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene.
    Levy JR; Ullrich A; Olefsky JM
    J Clin Invest; 1988 May; 81(5):1370-7. PubMed ID: 3284910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence supporting a two-receptor model for insulin binding by cultured embryonic heart cells.
    Wheeler FB; Santora AC; Elsas LJ
    Endocrinology; 1980 Jul; 107(1):195-207. PubMed ID: 6991248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-molecular-weight aggregates of therapeutic insulin. In vitro measurements of receptor binding and bioactivity.
    Robbins DC; Hirshman M; Wardzala LJ; Horton ES
    Diabetes; 1988 Jan; 37(1):56-9. PubMed ID: 3121417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of insulin and proinsulin on diaphragm and epididymal fat pads in rats.
    Kitabchi AE; Duckworth WC; Benson B
    Diabetes; 1972 Sep; 21(9):935-8. PubMed ID: 5055719
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytes.
    Duckworth WC; Peavy DE; Hamel FG; Liepnieks J; Brunner MR; Heiney RE; Frank BH
    Biochem J; 1988 Oct; 255(1):277-84. PubMed ID: 2848505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM; Piron MA; De Meyts P
    Diabetes Care; 1981; 4(2):209-14. PubMed ID: 7011729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding and biological effect of insulin in human adipocytes.
    Andersen O; Gliemann J; Gammeltoft S
    Diabetologia; 1977 Dec; 13(6):589-93. PubMed ID: 590650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.